Calysta, Inc., a Menlo Park, CA-based developer of sustainable products to improve worldwide food security, raised $40m in Series D funding.
The round was led by Mitsui & Co. Ltd., Tokyo, Japan, with participation from Temasek, a Singapore-based investment company and current investors Cargill, the Municipal Employee Retirement System (MERS) of Michigan, Walden Riverwood Ventures, Aqua-Spark and Pangaea Ventures. In conjunction with the funding, Hitoshi Kudo, General Manager, Animal Nutrition Dept., Nutriscience Division, Nutrition & Agriculture Business Unit, from Mitsui and Suan Swee Tan, Managing Director, Investments Agribusiness and Biotech, from Temasek, will join the Calysta Board of Directors.
The company intends to use the funds to advance commercial scale manufacturing of its ingredients.
Led by Alan Shaw, Ph.D., President and CEO, Calysta is developing FeedKind® protein, a family of sustainable, traceable nutritional ingredients for fish, livestock and pets. In November 2016, the company and Cargill, along with several third-party investors, announced plans to invest in the creation of a gas fermentation facility in Memphis, TN, to produce FeedKind protein.
Calysta also operates a Market Introduction Facility in the United Kingdom supplying sample quantities of FeedKind protein for customers.